Robert A. Ortenzio - Feb 8, 2024 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Role
EXECUTIVE CHAIRMAN, Director
Signature
/s/ Michael E. Tarvin, Attorney-in-Fact
Stock symbol
SEM
Transactions as of
Feb 8, 2024
Transactions value $
-$1,300,000
Form type
4
Date filed
2/9/2024, 04:34 PM
Previous filing
Jan 9, 2024
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEM Common Stock Sale -$1.3M -50K -0.73% $26.00 6.79M Feb 8, 2024 Direct F1, F2
holding SEM Common Stock 1.28M Feb 8, 2024 By the Robert A. Ortenzio Descendants Trust F3
holding SEM Common Stock 3.8M Feb 8, 2024 By the Rocco A. Ortenzio Separate Exempt Descendants Trust F3
holding SEM Common Stock 280K Feb 8, 2024 By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio F3
holding SEM Common Stock 280K Feb 8, 2024 By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio F3
holding SEM Common Stock 280K Feb 8, 2024 By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.685 to $26.31, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F3 The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.